Market Overview:
The global enzyme immunoassay analyzer market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for automated and semi-automated enzyme immunoassay analyzers from biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, research and academic institutes, and other end users. Additionally, the growing prevalence of various diseases is also contributing to the growth of this market.
Product Definition:
An enzyme immunoassay analyzer is a device used to measure the amount of an antibody or antigen in a sample. The importance of enzyme immunoassay analyzers is that they allow for the detection and quantification of specific proteins in samples, which can be used to diagnose diseases or monitor treatment progress.
Automated Enzyme Immunoassay Analyzer:
The global Automated Enzyme Immunoassay (AEIA) analyzer market was valued at USD 1.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Semi Auto Enzyme Immunoassay Analyzer:
Semi-automated Enzyme Immunoassay (EIA) analyzers are used for the quantitative determination of specific antibodies in biological fluids. These devices are majorly used in pharmaceutical industries to test the presence of drugs or their metabolites in samples. The increasing prevalence of diseases such as cancer, diabetes, and autoimmune disorders has led to a rise in demand for these types of devices globally.
Application Insights:
The biotechnology and pharmaceutical companies segment dominated the global enzyme immunoassay analyzer market in terms of revenue share in 2017. This is attributed to the rising prevalence of chronic diseases, such as cancer, diabetes mellitus, autoimmune disorders & allergies that require a high degree of specificity for diagnosis. Moreover, increasing R&D investments by biotechnology and pharmaceutical companies for developing new drugs are further expected to boost product demand over the forecast period.
Hospitals and diagnostic laboratories are also anticipated to witness lucrative growth over the forecast period owing to an increase in patient visits with regard to infectious diseases along with an increase in government initiatives for improving healthcare infrastructure across various regions globally. For instance, Germany¢â‚¬â„¢s Klinikum GroŽrlabe GmbH has developed a mobile lab that provides rapid testing options through EIIA-based tests at its hospital laboratory.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2016. The dominance can be attributed to factors such as increasing R&D investments, presence of key players, and high adoption rate for technologically advanced products. Moreover, growing focus on drug discovery by major pharmaceutical companies is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure and initiatives taken by governments across various countries including China & India for improving healthcare infrastructure at a domestic level. In addition, favorable government policies aimed at promoting generic drugs manufacturing are also likely to contribute toward regional growth over the next eight years time frame.
The European region accounted for more than 20% of global revenue share in 2016 due with presence of leading pharmaceutical companies that are actively involved in research activities relatedto immunoassays used across several end-use industries such as clinical testing laboratories.
Growth Factors:
- Increasing demand for rapid and accurate diagnosis of various diseases
- Technological advancements in the field of immunoassays
- Growing prevalence of target diseases that can be diagnosed through enzyme immunoassay analyzers
- Rising number of clinical laboratories and hospitals
- Increasing awareness about the benefits of enzyme immunoassay analyzers
Scope Of The Report
Report Attributes
Report Details
Report Title
Enzyme Immunoassay Analyzer Market Research Report
By Type
Automated Enzyme Immunoassay Analyzer, Semi Auto Enzyme Immunoassay Analyzer
By Application
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes
By Companies
Fujirebio, Beckman Coulter, Inc., ORGENTEC Diagnostika GmbH, Abbott Laboratories, Tosoh, Ortho-Clinical Diagnostic, Inc., Roche Diagnostics GmbH, Laibo Bio, Meril Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Enzyme Immunoassay Analyzer Market Report Segments:
The global Enzyme Immunoassay Analyzer market is segmented on the basis of:
Types
Automated Enzyme Immunoassay Analyzer, Semi Auto Enzyme Immunoassay Analyzer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fujirebio
- Beckman Coulter, Inc.
- ORGENTEC Diagnostika GmbH
- Abbott Laboratories
- Tosoh
- Ortho-Clinical Diagnostic, Inc.
- Roche Diagnostics GmbH
- Laibo Bio
- Meril Life Sciences
Highlights of The Enzyme Immunoassay Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automated Enzyme Immunoassay Analyzer
- Semi Auto Enzyme Immunoassay Analyzer
- By Application:
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enzyme Immunoassay Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An enzyme immunoassay analyzer is a laboratory instrument that uses enzymes to identify specific proteins in a sample. The analyzer separates the proteins based on their unique chemical signatures, and then measures the amount of each protein present in the sample. This information can then be used to determine which proteins are present and how much they are likely to contribute to the overall analysis.
Some of the key players operating in the enzyme immunoassay analyzer market are Fujirebio, Beckman Coulter, Inc., ORGENTEC Diagnostika GmbH, Abbott Laboratories, Tosoh, Ortho-Clinical Diagnostic, Inc., Roche Diagnostics GmbH, Laibo Bio, Meril Life Sciences.
The enzyme immunoassay analyzer market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Enzyme Immunoassay Analyzer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Enzyme Immunoassay Analyzer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Enzyme Immunoassay Analyzer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Enzyme Immunoassay Analyzer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Enzyme Immunoassay Analyzer Market Size & Forecast, 2018-2028
4.5.1 Enzyme Immunoassay Analyzer Market Size and Y-o-Y Growth
4.5.2 Enzyme Immunoassay Analyzer Market Absolute $ Opportunity
Chapter 5 Global Enzyme Immunoassay Analyzer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Enzyme Immunoassay Analyzer Market Size Forecast by Type
5.2.1 Automated Enzyme Immunoassay Analyzer
5.2.2 Semi Auto Enzyme Immunoassay Analyzer
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Enzyme Immunoassay Analyzer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Enzyme Immunoassay Analyzer Market Size Forecast by Applications
6.2.1 Biotechnology and Pharmaceutical Companies
6.2.2 Hospitals and Diagnostic Laboratories
6.2.3 Research and Academic Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Enzyme Immunoassay Analyzer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Enzyme Immunoassay Analyzer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Enzyme Immunoassay Analyzer Analysis and Forecast
9.1 Introduction
9.2 North America Enzyme Immunoassay Analyzer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Enzyme Immunoassay Analyzer Market Size Forecast by Type
9.6.1 Automated Enzyme Immunoassay Analyzer
9.6.2 Semi Auto Enzyme Immunoassay Analyzer
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Enzyme Immunoassay Analyzer Market Size Forecast by Applications
9.10.1 Biotechnology and Pharmaceutical Companies
9.10.2 Hospitals and Diagnostic Laboratories
9.10.3 Research and Academic Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Enzyme Immunoassay Analyzer Analysis and Forecast
10.1 Introduction
10.2 Europe Enzyme Immunoassay Analyzer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Enzyme Immunoassay Analyzer Market Size Forecast by Type
10.6.1 Automated Enzyme Immunoassay Analyzer
10.6.2 Semi Auto Enzyme Immunoassay Analyzer
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Enzyme Immunoassay Analyzer Market Size Forecast by Applications
10.10.1 Biotechnology and Pharmaceutical Companies
10.10.2 Hospitals and Diagnostic Laboratories
10.10.3 Research and Academic Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Enzyme Immunoassay Analyzer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Enzyme Immunoassay Analyzer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Enzyme Immunoassay Analyzer Market Size Forecast by Type
11.6.1 Automated Enzyme Immunoassay Analyzer
11.6.2 Semi Auto Enzyme Immunoassay Analyzer
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Enzyme Immunoassay Analyzer Market Size Forecast by Applications
11.10.1 Biotechnology and Pharmaceutical Companies
11.10.2 Hospitals and Diagnostic Laboratories
11.10.3 Research and Academic Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Enzyme Immunoassay Analyzer Analysis and Forecast
12.1 Introduction
12.2 Latin America Enzyme Immunoassay Analyzer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Enzyme Immunoassay Analyzer Market Size Forecast by Type
12.6.1 Automated Enzyme Immunoassay Analyzer
12.6.2 Semi Auto Enzyme Immunoassay Analyzer
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Enzyme Immunoassay Analyzer Market Size Forecast by Applications
12.10.1 Biotechnology and Pharmaceutical Companies
12.10.2 Hospitals and Diagnostic Laboratories
12.10.3 Research and Academic Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Enzyme Immunoassay Analyzer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Enzyme Immunoassay Analyzer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Enzyme Immunoassay Analyzer Market Size Forecast by Type
13.6.1 Automated Enzyme Immunoassay Analyzer
13.6.2 Semi Auto Enzyme Immunoassay Analyzer
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Enzyme Immunoassay Analyzer Market Size Forecast by Applications
13.10.1 Biotechnology and Pharmaceutical Companies
13.10.2 Hospitals and Diagnostic Laboratories
13.10.3 Research and Academic Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Enzyme Immunoassay Analyzer Market: Competitive Dashboard
14.2 Global Enzyme Immunoassay Analyzer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fujirebio
14.3.2 Beckman Coulter, Inc.
14.3.3 ORGENTEC Diagnostika GmbH
14.3.4 Abbott Laboratories
14.3.5 Tosoh
14.3.6 Ortho-Clinical Diagnostic, Inc.
14.3.7 Roche Diagnostics GmbH
14.3.8 Laibo Bio
14.3.9 Meril Life Sciences
